Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-07

Clinical Trial Update: Efficacity of a Standardized Hypnotic Message During the Application of a Qutenza (Capsaicin) 8% Patch [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy of a standardized hypnotic message during application of a Qutenza (capsaicin) 8% patch for pain relief.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • QUTENZA (Capsaicin)

Snippet

Sponsor: Institut de Cancérologie de Lorraine | Conditions: Pain | Phase 3 | Status: COMPLETED